(Q48097785)

8 February 2018

title

Glial growth factor 2 promotes functional recovery with treatment initiated up to 7 days after permanent focal ischemic stroke (English)

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

18 June 2024

author name string

Anindita Ganguly

2

1 reference

8 February 2018

Jingmei Ren

5

1 reference

8 February 2018

Subhash Saha

6

1 reference

8 February 2018

Maya Srinivas

8

1 reference

8 February 2018

Jennifer F. Iaci

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691195

18 June 2024

Seth P. Finklestein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691195

18 June 2024

Tom J. Parry

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691195

18 June 2024

Dana K. Sietsma

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691195

18 June 2024

Andrea M. Vecchione

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691195

18 June 2024

Anthony O. Caggiano

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691195

18 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20691195

18 June 2024

publication date

4 August 2010

1 reference

8 February 2018

full work available at URL

number of pages

10

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0028390810001784?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

https://api.elsevier.com/content/article/PII:S0028390810001784?httpAccept=text/plain

18 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

18 June 2024

1 reference

8 February 2018

volume

59

1 reference

8 February 2018

issue

7-8

1 reference

8 February 2018

page(s)

640-649

1 reference

8 February 2018

Enriched rehabilitative training promotes improved forelimb motor function and enhanced dendritic growth after focal ischemic injury.

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism

18 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neuregulin and ErbB receptor signaling pathways in the nervous system

18 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neuregulins and neuronal plasticity: possible relevance in schizophrenia.

18 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Gene expression changes after focal stroke, traumatic brain and spinal cord injuries

18 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neuregulins and their receptors

18 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Nan fang yi ke da xue xue bao

18 June 2024

7

28

1771

Chen

2008

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neuroprotection for ischemic stroke: two decades of success and failure

18 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Time course, localization and pharmacological modulation of immediate early inducible genes, brain-derived neurotrophic factor and trkB messenger RNAs in the rat brain following photochemical stroke.

18 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery

18 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Repairing the human brain after stroke. II. Restorative therapies

18 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2

18 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neocortical localization of tactile/proprioceptive limb placing reactions in the rat.

18 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Physical exercise and cognitive recovery in acquired brain injury: a review of the literature

18 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neuregulins rescue PC12-ErbB-4 cells from cell death induced by beta-amyloid peptide: involvement of PI3K and PKC.

18 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

The neuregulin GGF2 attenuates free radical release from activated microglial cells

18 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

NRG1 and synaptic function in the CNS.

18 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Akt-mediated survival of oligodendrocytes induced by neuregulins.

18 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

The efficacy of stroke rehabilitation: a qualitative review

18 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Thrombolytic Therapy in Acute Ischemic Stroke

18 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke

18 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Brain plasticity and stroke rehabilitation. The Willis lecture

18 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience

18 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors

18 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neuregulin-1 and myelination

18 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity.

18 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat.

18 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neuroprotection by neuregulin-1 in a rat model of permanent focal cerebral ischemia

18 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

18 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Robot-assisted therapy for long-term upper-limb impairment after stroke

18 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neuroprotection and repair by neurotrophic and gliotrophic factors in multiple sclerosis

18 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury

18 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neuregulin 1 in neural development, synaptic plasticity and schizophrenia

18 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neuregulin links dopaminergic and glutamatergic neurotransmission to control hippocampal synaptic plasticity

18 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Tissue plasminogen activator for acute ischemic stroke

18 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke.

18 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Widespread up-regulation of N-methyl-D-aspartate receptors after focal photothrombotic lesion in rat brain

18 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Widespread and long-lasting alterations in GABA(A)-receptor subtypes after focal cortical infarcts in rats: mediation by NMDA-dependent processes

18 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials

18 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial

18 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke

18 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Behavioral tests for preclinical intervention assessment

18 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia.

18 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

18 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat.

18 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

18 June 2024

49

38

747

Tamura

1986

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Post-stroke inflammatory response: effects of stroke evolution and outcome

18 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Type III neuregulin-1 promotes oligodendrocyte myelination

18 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

rhGGF2 protects against cisplatin-induced neuropathy in the rat

18 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neuroprotectants in the treatment of stroke--an overview

18 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neuregulin-1 enhances depolarization-induced GABA release

18 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Extended therapeutic window and functional recovery after intraarterial administration of neuregulin-1 after focal ischemic stroke

18 June 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression

18 June 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neuregulin-1 is neuroprotective and attenuates inflammatory responses induced by ischemic stroke

18 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

Neurotrophic and neuroprotective effects of the neuregulin glial growth factor-2 on dopaminergic neurons in rat primary midbrain cultures

18 June 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.07.017

18 June 2024

Identifiers

1 reference

8 February 2018

1 reference

8 February 2018